News
HSIC
80.10
+0.48%
0.38
Henry Schein Reaches Analyst Target Price
NASDAQ · 18h ago
Weekly Report: what happened at HSIC last week (0202-0206)?
Weekly Report · 19h ago
1 Safe-and-Steady Stock with Solid Fundamentals and 2 That Underwhelm
Barchart · 1d ago
Assessing Henry Schein’s Valuation As Recent Share Price Momentum Draws Fresh Investor Attention
Simply Wall St · 1d ago
Is Henry Schein’s (HSIC) Slower Organic Growth Reframing Its Competitive Moat in Healthcare Distribution?
Simply Wall St · 2d ago
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program
Barchart · 4d ago
Dental sector may steady in 2026, but full recovery remains distant, analysts say
Reuters · 5d ago
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and Azenta (AZTA)
TipRanks · 5d ago
Weekly Report: what happened at HSIC last week (0126-0130)?
Weekly Report · 02/02 10:11
Assessing Henry Schein’s Valuation After Greenlight Capital’s Push For Operational Improvements
Simply Wall St · 01/31 12:23
Jefferies EU medical tech analyst holds analyst/industry conference call
TipRanks · 01/29 21:25
Weekly Report: what happened at HSIC last week (0119-0123)?
Weekly Report · 01/26 10:11
How Investors Are Reacting To Henry Schein (HSIC) New CEO Pick And Exclusive CitoCBC Deal
Simply Wall St · 01/22 12:41
Press Release: Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET
Dow Jones · 01/22 11:32
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Agios Pharma (AGIO) and Henry Schein (HSIC)
TipRanks · 01/22 11:30
Henry Schein Inc. to Webcast Fourth Quarter 2025 Earnings Call
Reuters · 01/22 11:30
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET
Barchart · 01/22 05:30
Henry Schein Is Maintained at Neutral by Mizuho
Dow Jones · 01/20 14:12
Mizuho Maintains Neutral on Henry Schein, Raises Price Target to $81
Benzinga · 01/20 14:02
HENRY SCHEIN INC <HSIC.O>: MIZUHO RAISES TARGET PRICE TO $81 FROM $74
Reuters · 01/20 11:44
More
Webull provides a variety of real-time HSIC stock news. You can receive the latest news about Henry Schein through multiple platforms. This information may help you make smarter investment decisions.
About HSIC
Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.